Market News
Stay updated with the latest market trends, earnings, and economic indicators.
China stocks mixed as weak consumer and property data offset industrial strength
Investor sentiment was weighed down by signs of uneven economic recovery. China's new home prices fell for a 35th straight month, remaining at their sharpest pace of decline since May 2025. Fixed-asset investment growth for JanuaryMay also missed expectations, while retail sales unexpectedly contracted in May, marking their first annual decline since December 2022.
Nifty at 25,000 could be a profit-booking opportunity: Rahul Arora
Rahul Arora, CEO of Ashika Institutional Equities remains selective on consumer stocks, favouring Britannia, Tata Consumer and Nestle, while preferring Eternal over Swiggy in the internet space due to stronger growth prospects and lower losses.
Carnival Time! Auto cos on a roll as demand stays strong
Indian auto sales experienced robust double-digit growth in May, with passenger vehicles up 27% and two-wheelers by 31%. This surge, driven by a favorable base effect, GST rate cuts, and easier financing, saw record May sales for passenger vehicles, three-wheelers, and two-wheelers, despite global economic uncertainties.
Ahead of Market: 10 things that will decide stock market action on Tuesday
Indian equities rallied sharply as an interim US-Iran peace framework eased geopolitical concerns and pushed oil prices lower. Improved inflation and interest-rate expectations lifted sentiment, helping Sensex and Nifty gain nearly 1%, while broader markets, global equities and risk assets also advanced.
Wall Street week ahead: Spotlight on Federal Reserve rate decision, retail sales, Middle East, G7 summit
Market participants will be looking for signals on how the new Fed chief Kevin Warsh intends to tackle lingering inflation concerns while balancing economic growth
Global air travel demand to slow to 2.1% in 2026, IATA says
Global air travel demand is set to grow in 2026, but at a slower rate. The Middle East faces a significant contraction due to ongoing conflicts. Africa is projected for the strongest growth. Asia Pacific will lead global expansion. Europe and Latin America will see moderate increases. North America's growth will be limited. The industry shows adaptability despite challenges.
Goldman Sachs, Morgan Stanley and others buy stake in Rs 1,960 crore Lenskart block deal
ADIA-backed Platinum Jasmine A 2018 Trust sold a 2.3% stake in Lenskart through a Rs 1,960 crore block deal. The transaction attracted strong participation from mutual funds, insurers and foreign investors, reflecting continued confidence in the eyewear retailer’s growth prospects.
HFCs emerge stronger after FY26 stress, asset quality recovers sharply; sector better placed for FY27: Report
Housing finance companies have emerged stronger after facing challenges. Asset quality has improved significantly. Loan growth is picking up, and profitability remains resilient. The sector saw a broad-based recovery in the fourth quarter of FY26. This was supported by better collections and healthy disbursement growth. HFCs are now better positioned to handle future challenges.
Zee Entertainment plans to raise at least ₹2,300 crore for future growth
ZEEL board approves plan to raise at least 2300 crore in phases to fund strategic and business initiatives, including expansion after securing FIFA broadcasting rights
ICICI Prudential Mutual Fund raises stake in Travel Food Services, shares rise
ICICI Prudential Mutual Fund has announced the acquisition of an additional stake in Travel Food Services, increasing its total shareholding in the company to above 5%.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.